Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus
Eli Lilly has signed a definitive agreement with Nexus Pharmaceuticals wherein Lilly will be acquiring a manufacturing facility from Nexus.
Nexus Pharmaceuticals | 23/04/2024 | By Aishwarya | 175
Nexus Pharmaceuticals receives FDA inspection of pharma manufacturing facility in Wisconsin
The Pleasant Prairie facility, which spans more than 84,000 square feet, is equipped with state-of-the-art isolator technology and adheres to the highest current good manufacturing practice (CGMP) standards
Nexus Pharmaceuticals | 08/05/2023 | By Sudeep Soparkar | 489
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy